Skip to main content
. Author manuscript; available in PMC: 2013 Sep 15.
Published in final edited form as: Int J Cancer. 2012 Jan 11;131(6):1417–1422. doi: 10.1002/ijc.27390

Table 2.

Adjusted odds ratios (and 95% confidence intervals) for esophageal and gastric adenocarcinoma in relation to diabetes.

Controls EA
GCA
DGA
Cases OR (95% CI)1 P1 Cases OR (95% CI)1 P1 Cases OR (95% CI)1 P1
No diabetes 1197 178 1.00 (ref) 233 1.00 (ref) 327 1.00 (ref)
Diabetes 112 31 1.48 (0.94–2.32) 0.089 24 0.96 (0.59–1.55) 0.87 55 1.47 (1.01–2.15) 0.045
Duration of diabetes
 ≤2 years 17 6 1.69 (0.62–4.55) 0.30 6 1.42 (0.54–3.77) 0.48 9 1.78 (0.74–4.30) 0.20
 >2–10 yrs 37 13 1.82 (0.92–3.61) 0.084 12 1.42 (0.71–2.82) 0.32 25 1.89 (1.07–3.34) 0.028
 >10 yrs 58 12 1.19 (0.61–2.33) 0.61 6 0.50 (0.21–1.18) 0.12 21 1.11 (0.63–1.94) 0.72

Abbreviations: EA, esophageal adenocarcinoma; GCA, gastric cardia adenocarcinoma; DGA, distal gastric adenocarcinoma; OR, odds ratio; CI, confidence interval; NOK, next of kin.

1

Results were estimated from multivariate unconditional polytomous logistic regression, with adjustment for age, sex, race, education, birth place, cigarette smoking status and body mass index.